Scientific Advisory Board
Daniel D. Von Hoff, MD, FACP (Chairman)
Professor of Medicine, Pathology, Molecular and Cellular Biology, and Director, the Arizona Health Sciences Center's Cancer Therapeutics Program. Dr. Von Hoff's major interest is in the development of new anticancer agents, both in the clinic and in the laboratory (including mitoxantrone, fludarabine, paclitaxel, docetaxel, gemcitabine, CPT-11). He has published more than 515 papers, 127 book chapters, and more than 850 abstracts, and is former President of AACR and former board member of ASCO. He is a founder of ILEX Oncology, Inc. (acquired by Genzyme). He is founder and Editor Emeritus of Investigational New Drugs - The Journal of New Anticancer Agents; and, Editor-in-Chief of Molecular Cancer Therapeutics.
Donald W. Kufe, MD
Professor of Medicine, Harvard; Vice Director, Dana-Farber Cancer Institute. Dr. Kufe received his MD in 1970 from the University of Rochester School of Medicine, and postgraduate training at Harvard’s Beth Israel Hospital. Subsequently, he undertook extensive laboratory-based research in molecular virology at Columbia’s Institute of Cancer Research. In 1979, he joined Dana-Farber. He has served as Chief of the Division of Cancer Pharmacology, Deputy Director of the Dana-Farber Cancer Center, Director of the Harvard Phase I Oncology Group and Leader of the Experimental Therapeutics Program. He has served as the senior editor of Cancer Medicine, one of the major text books in oncology, and on the editorial board of multiple international cancer research journals.
William G. Dunphy, PhD
Professor, California Institute of Technology, Researcher, Howard Hughes Medical Institute and Adjunct Assistant Professor of Biochemistry and Molecular Biology at the USC School of Medicine. He holds an A.B. degree in Biochemical Sciences from Harvard College and Ph.D. in biochemistry from Stanford University. He was a Helen Hay Whitney postdoctoral fellow at the University of California, San Diego. His honors include a scholar award from the Lucille P. Markey Charitable Trust and a presidential young investigator award from the National Science Foundation. Dr. Dunphy is interested in the biochemical mechanisms controlling the entry into mitosis in vertebrate cells.